BSECompany Update2d ago · 12 Aug 2026, 03:30 pm
as attached
Eris Lifesciences Ltd · 540596
✦ AI SummaryMgmt Change
Eris Lifesciences Ltd has announced an analyst/institutional investor meeting on August 17, 2026, where the management will discuss publicly available documents and no unpublished price-sensitive information will be disclosed.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
e0b008af-b832-4a37-b8f9-289a8550420c.pdf
View document text
Date: 12August 2026
To To
BSE Limited National StockExchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza
Dalal Street Bandra Kurla Complex
Mumbai –400001 Bandra (E)
Mumbai –400051
SecurityCode: 540596 Symbol: ERIS
SUBJECT: INTIMATION OFSCHEDULE OFANALYST / INSTITUTIONAL INVESTORMEETING
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we
wish to inform you that the Management of Eris Lifesciences Limited will be participating in the following
Investor Conferences:
Management Mode of
Day and Date Fund Name Meeting Details
Representatives Meeting
Tokio MarineAsset
Monday, Mr. Krishnakumar 12:00 PM IST,
Management Co. Virtual
Aug 17, 2026 Vaidyanathan 1X1
Ltd.
The above schedule is indicative and issubject tochanges necessitated by any unforeseen developments.
The company will be referringto publicly available documents for discussions during interaction inthe meeting
and no unpublished price sensitive information(UPSI) is intendedto bediscussed duringtheinteraction.
Thanking You,
For Eris Lifesciences Limited
MilindTalegaonkar
Company Secretary &ComplianceOfficer
MembershipNo: A26493